General Atlantic, a leading global growth equity firm, announced today that Michelle Dipp, M.D., Ph.D., Co-Founder and former General Partner of Longwood Fund, has joined General Atlantic as a Managing Director in the firm’s New York office. Dr. Dipp will be a senior member of the firm’s Global Healthcare team and will focus on biopharma and life sciences investments.

“We are excited to welcome Michelle to General Atlantic and look forward to leveraging her deep knowledge and extensive healthcare industry expertise,” said Bill Ford, Chief Executive Officer of General Atlantic. “As we continue to expand our healthcare aperture, we believe Michelle’s experience as a successful entrepreneur and operator, combined with her scientific and clinical expertise, make her incredibly well-suited to General Atlantic’s style of hands-on growth investing.”

“General Atlantic has built an internationally respected healthcare platform and a track record of strong partnerships with healthcare CEOs and management teams,” said Dr. Dipp. “I look forward to working closely with the entire team to help identify innovative growth companies in the healthcare sector that we can help take to the next level.”

“As we continue to build our global healthcare expertise, we are thrilled to add an executive and investor with significant life sciences experience and technical knowledge,” said Robbert Vorhoff, Managing Director and Global Head of Healthcare at General Atlantic. “We believe that Michelle will add substantial value to our global team, both in terms of identifying new healthcare investment opportunities and serving as a resource to our portfolio of healthcare companies.”

Prior to joining General Atlantic, Dr. Dipp most recently served as Co-Founder and General Partner of Longwood Fund, a healthcare venture capital firm. In this role, she served as a General Partner in Longwood Funds I, II, III, and IV. Additionally, Dr. Dipp co-founded several Longwood Fund portfolio companies, where she held senior management and board positions, including co-founding Chairman of Axial Biotherapeutics as well as co-founding CEO, and later Chairman, of OvaScience, Inc. Dr. Dipp also served as a Co-Founder of Longwood Fund portfolio companies Alnara Pharmaceuticals, Inc., Flex Pharma, Inc., and Verastem, Inc., as well as a board member of Colorescience and as a board observer of Bicycle Therapeutics and Pulmocide Ltd.

Prior to Longwood Fund, Dr. Dipp served as GlaxoSmithKline’s (GSK) Senior Vice President of the Centre of Excellence for External Drug Discovery (CEEDD), GSK’s global business development group. Prior to GSK, Dr. Dipp served as Vice President of Corporate Development of Sirtris Pharmaceuticals, Inc., a biotechnology company, which was acquired by GSK.

Dr. Dipp is a member of the World Economic Forum’s Young Global Leaders and currently serves on the Board of Directors for Life Science Cares. She is also a women’s health contributor for Arianna Huffington’s Thrive Global. Dr. Dipp formerly served on the Biotechnology Industry Organization’s (BIO) Emerging Companies Governing Board, the New England Venture Capital Association (NEVCA) Board of Directors, the Beth Israel Deaconess Medical Center Board of Directors, the Boston Symphony Orchestra Board of Overseers, and the City on a Hill Charter School Board of Directors.

She holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford.

Drawing from 37 years of experience investing in over 250 global growth companies, General Atlantic partners with entrepreneurs and management teams who are building leading, high-growth businesses. The firm has $21 billion of assets under management as of June 30, 2017. General Atlantic focuses on investments across five sectors, including Internet & Technology, Financial Services, Business Services, Retail & Consumer, and Healthcare, with support from the firm’s global team of experts. The firm has deep expertise in the Healthcare sector and is currently invested in leading healthcare companies including Alignment Healthcare, A Place for Mom, CitiusTech, eviCore Healthcare, Oak Street Health, Ourofino, Sanfer, Sonendo, and Synaptive.

About General Atlantic

General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Established in 1980, General Atlantic combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to build exceptional businesses worldwide. General Atlantic has more than 100 investment professionals based in New York, Amsterdam, Beijing, Greenwich, Hong Kong, London, Mexico City, Mumbai, Munich, Palo Alto, São Paulo, and Singapore. www.generalatlantic.com.